Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacyclics (PCYC) -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (419)	3/23/1999 10:04:00 AM
From: Harold Engstrom	Read Replies (1) \| Respond to of 717

Hi, Peter! You are not alone! This press release is OK. I would like some detail on efficacy and on timelines for all the PCYC products in the clinic. I emailed the company last week and was told that if I wanted any information, then I would have to call and talk with someone. That usually means that the company has no confidence in what it is saying and doesn't want to write anything down. Too bad. Gd Tex and Antrin are so promising in theory. Wouldn't it be nice to see clinical progress? What is the fate of the approvable product that PCYC brought through Phase III at the end of 1996 and is still waiting PCYC action before the FDA can approve or disapprove?